Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 74 filings·Updated 25 Sept 2026
Showing 10 of 74 filings.
25 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Syngene International Ltd – Closure of Trading Window from October 1, 2026 till 48 hours after the declaration of unaudited financial results for the quarter and half year ending September 30, 2026

Syngene International Ltd – Closure of Trading Window from October 1, 2026 till 48 hours after the declaration of unaudited financial results for the quarter and half year ending September 30, 2026

Filed 17:25View Source
21 Sept 20263 filings
Company UpdateChange in Directorate

Syngene International Limited has informed the Exchange about Resignation of Director/KMP/SMP

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 23:24View Source
Company UpdateChange in Directorate

Syngene reports resignation of Head Corporate Affairs & Communications, effective Sept 21, 2026

Resignation of Head – Corporate Affairs & Communications

  • Mr. Pramuch Goel, Head of Corporate Affairs & Communications, resigns effective Sept 21, 2026 to pursue career opportunities.
Filed 22:50View Source
Company UpdateAnalyst / Investor Meet

Syngene schedules online one-on-one investor meeting with Bajaj AMC on September 24, 2026

Meeting Details

  • Date: September 24, 2026; Time: 12:00 IST.
  • Type/Mode: One-on-one, online.
  • Venue: Bengaluru.
  • Event/Organizer: Schedule of Meeting with Analyst/Institutional Investor (Syngene).

Purpose

  • Purpose: Schedule for one-on-one investor meeting with Bajaj AMC.

Additional Notes

  • No UPSI will be disclosed during the meeting.
  • Information will be made available on the company's website.
Filed 17:48View Source
12 Sept 20261 filing
Company UpdateAnalyst / Investor Meet

Syngene to attend Kotak Healthcare Forum 2026 in Mumbai on Sept 17

Meeting Details

  • Date and time: September 17, 2026 at 09:00 IST.
  • Type and mode: Physical, group / one-on-one investor conference.
  • Event/organiser: Healthcare Forum 2026 organized by Kotak.
  • Venue: Mumbai.
  • Purpose: Investor interaction with analysts/institutional investors.
  • Key company participants: not disclosed.
Filed 20:26View Source
11 Sept 20261 filing
Company UpdateAnalyst / Investor Meet

Syngene schedules virtual one-on-one investor meeting with True Beacon PMS on Sept 17, 2026

Meeting Details

  • Sept 17, 2026, 12:00 PM IST
  • One-on-one; Virtual
  • Analyst/Investor: True Beacon PMS
  • Venue: Bengaluru
  • Purpose: Investor interaction with analyst
  • Company participant: Company Secretary & Compliance Officer
Filed 19:20View Source
10 Sept 20261 filing
Company UpdateGeneral

Syngene announces final dividend of 12.50% for FY2025-26 and remittance underway

Dividend remittance for FY2025-26

  • Final dividend of 12.50% (Rs 1.25 per share) for FY2025-26 approved at AGM on 29 July 2026.
  • Remittance completed via warrant or electronic mode per shareholder mandates.
  • Communication sent to shareholders lacking registered email but with address on file.
  • Details of remittance and credit information will be available on the company website.
  • Registrar and transfer agent for queries: KFin Technologies Limited.
  • This notice is dated 10 September 2026.
Filed 17:18View Source
25 Aug 20261 filing
Company UpdateAnalyst / Investor Meet

Syngene to host in-person analyst meeting at Goldman Sachs Asia Leaders Conference in Hong Kong (Aug 31–Sep 1, 2026).

Meeting Details

  • Dates: August 31, 2026 to September 1, 2026.
  • In-person group/one-on-one meeting.
  • Event: Goldman Sachs Asia Leaders Conference.
  • Venue: Hong Kong.
  • Purpose: Analyst/institutional investor interaction.
  • Presentation will be available on the company website.

Notes

  • UPSI will not be disclosed at the meeting.
Filed 16:34View Source
24 Aug 20262 filings
Company UpdateAcquisition

Syngene to acquire 12.44% stake in Ampin C&I Power Twelve Private Limited for captive renewable energy

Acquisition details

  • Target: AMPIN C&I Power Twelve Private Limited, renewable energy generation, incorporated 23 April 2025, Delhi, India.
  • Net worth Rs 687.70 lakhs; FY2025-26 turnover NIL; PAT Rs 0.31.
  • Acquisition not a related party; promoters have no interest.
  • Industry: Renewable energy generation.
  • Purpose: Enhance renewable-based power; maintain captive status; support decarbonization and reduce costs.
  • Regulatory approvals: Not applicable.
  • Timeline: Allotment within 30 days or mutually agreed.
  • Consideration: Cash; INR 2.52 crore for 2,520,000 shares at INR 10.
  • Equity stake: 12.44% undiluted; minimum 7.93% fully diluted post other investments.
  • Background: AMPIN focuses on renewable energy; incorporated 23 Apr 2025; turnover FY2025-26 NIL; presence in India.
  • Turnover history: FY2025-26 NIL; FY2024-25 NIL; FY2023-24 not disclosed.
Filed 18:06View Source
Company UpdateAnalyst / Investor Meet

Syngene schedules virtual one-on-one investor meeting with Entrust Family Office on Aug 28, 2026

Meeting Details

  • Date: August 28, 2026.
  • Timings: 12:00 PM IST.
  • Type/Mode: One-on-one, virtual meeting.
  • Organiser: Entrust Family Office.
  • Purpose: Investor meeting with an analyst/institutional investor.
  • Venue: Bangalore.
  • Materials: Presentation materials to be available on the company website.
Filed 14:54View Source
Showing 10 of 74 filings